23 Although our meta-analysis identified a trend toward reduced binge-eating episodes, BMI, body weight, depressive symptoms, total cholesterol, LDL cholesterol, and HDL cholesterol, these findings did not reach statistical significance, likely due to the insufficient sample size.
← all excerpts
Naltrexone-bupropion for the treatment of binge eating disorder: a systematic review and meta-analysis.
1
—
—